3M launches two new respirators

These two respirators – 3M Particulate Respirator 8612F and 3M Particulate Respirator 8670F – are said to be unique because they are the first to receive clearance by the FDA to reduce exposure to airborne germs during a public health medical emergency such as an influenza pandemic.

The FDA outlined a special clearance process for N95 respirators used by the general public in public health medical emergencies in order to provide reasonable assurance of their safety and effectiveness.

Julie Bushman, division vice-president of occupational health and environmental safety division at 3M, said: “The release of these FDA-N95 respirators is a significant step in providing the public with guidance and products needed to help reduce exposure to airborne germs.”